Ventricular rate during acute atrial fibrillation and outcome of electrical cardioversion: The FinCV Study

References

• Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12:1360–420.
   PubMed Web of Science ®Google Scholar
• Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129:837–47.
   PubMed Web of Science ®Google Scholar
• Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113:359–64.
   PubMed Web of Science ®Google Scholar
• Michael JA, Stiell IG, Agarwal S, Mandavia DP. Cardioversion of paroxysmal atrial fibrillation in the emergency department. Ann Emerg Med. 1999;33:379–87.
   PubMed Web of Science ®Google Scholar
• Burton JH, Vinson DR, Drummond K, Strout TD, Thode HC, McInturff JJ. Electrical cardioversion of emergency department patients with atrial fibrillation. Ann Emerg Med. 2004;44:20–30.
   PubMed Web of Science ®Google Scholar
• Botkin SB, Dhanekula LS, Olshansky B. Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs. Am Heart J. 2003; 145:233–8.
   PubMed Web of Science ®Google Scholar
• Pisters R, Nieuwlaat R, Prins MH, Le Heuzey JY, Maggioni AP, Camm AJ, et al. Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey. Europace. 2012;14:666–74.
   PubMed Web of Science ®Google Scholar
• Kim SK, Pak HN, Park JH, Ko KJ, Lee JS, Choi JI, et al. Clinical and serological predictors for the recurrence of atrial fibrillation after electrical cardioversion. Europace. 2009;11:1632–8.
   PubMed Web of Science ®Google Scholar
• Airaksinen KEJ, Grönberg T, Nuotio I, Nikkinen M, Ylitalo A, Biancari F, et al. Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study. J Am Coll Cardiol. 2013;62:1187–92.
   PubMed Web of Science ®Google Scholar
• Grönberg T, Nuotio I, Nikkinen M, Ylitalo A, Vasankari T, Hartikainen JEK, et al. Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: The FinCV study. Europace. 2013;15:1432–5.
   PubMed Web of Science ®Google Scholar
• Nuotio I, Hartikainen JEK, Grönberg T, Biancari F, Airaksinen KEJ. Time to cardioversion for acute atrial fibrillation and thromboembolic complications. JAMA. 2014;312;647–9.
   PubMed Web of Science ®Google Scholar
• Obel OA, Luddington L, Maarouf N, Aytemir K, Ekwall C, Malik M, et al. Effects of ventricular rate and regularity on the velocity and magnitude of left atrial appendage flow in atrial fibrillation. Heart. 2005;91:764–8.
   PubMed Web of Science ®Google Scholar
• Akosah KO, Funai JT, Porter TR, Jesse RL, Mohanty PK. Left atrial appendage contractile function in atrial fibrillation influence of heart rate and cardioversion to sinus rhythm. Chest. 1995; 107:690–6.
   PubMed Web of Science ®Google Scholar
• Climent AM, Guillem MS, Husser D, Castells F, Millet J, Bollmann A. Role of the atrial rate as a factor modulating ventricular response during atrial fibrillation. PACE. 2010;33:1510–17.
   Google Scholar
• Cooper HA, Sacco J, Solomon AJ, Feld GK, Leman R, Wilber D. Relation of initial resting ventricular rate to the ability to achieve and maintain normal sinus rhythm in patients with atrial fibrillation. Am J Cardiol. 2005;95:597–602.
   PubMed Web of Science ®Google Scholar
• Hnatkova K, Waktare JE, Murgatroyd FD, Guo X, Camm AJ, Malik M. Age and gender influences on rate and duration of paroxysmal atrial fibrillation. PACE. 1998;21:2455–8.
   Google Scholar
• Wolbrette D, Naccarelli G, Curtis A, Lehmann M, Kadish A. Gender differences in arrhythmias. Clin Cardiol. 2002;25:49–56.
   PubMed Web of Science ®Google Scholar
• Wasmund SL, Li JM, Page RL, Joglar JA, Kowal RC, Smith ML, et al. Effect of atrial fibrillation and an irregular ventricular response on sympathetic nerve activity in human subjects. Circulation. 2003; 107:2011–15.
   PubMed Web of Science ®Google Scholar
• Mäki T, Toivonen L, Koskinen P, Näveri H, Härkönen M, Leinonen H. Effect of ethanol drinking, hangover, and exercise on adrenergic activity and heart rate variability in patients with a history of alcohol-induced atrial fibrillation. Am J Cardiol. 1998;82:317–22.
   PubMed Web of Science ®Google Scholar
• Denison H, Jern S, Jagenburg R, Wendestam C, Wallerstedt S. Influence of increased adrenergic activity and magnesium depletion on cardiac rhythm in alcohol withdrawal. Br Heart J. 1994;72: 554–60.
   PubMedGoogle Scholar
• Varounis C, Dagres N, Maounis T, Panagiotakos D, Cokkinos DV. Atrial premature complexes and heart rate have prognostic significance in 1-month atrial fibrillation recurrence after electrical cardioversion. Europace. 2007; 9:633–7.
   PubMed Web of Science ®Google Scholar
• Psychari SN, Chatzopoulos D, Iliodromitis EK, Apostolou TS, Kremastinos DT. C-reactive protein, interleukin 6, and N-terminal pro-brain natriuretic peptide following cardioversion of atrial fibrillation: is there a role of biomarkers in arrhythmia recurrence? Angiology. 2011;62:310–16.
   PubMed Web of Science ®Google Scholar